MOH
Molina Healthcare, Inc. Health Care Hospital & Medical Service Plans Russell 3000
$204.78Close
$10.4BMarket cap
$122.65 – $242.8852-week range
Mid-januaryNext report · estimated
Highlights
Cautions
- Trend not confirmed 7 of 8 conditions · RS under 70
- Earnings shrinking EPS −51% year on year
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
16%
1wk
down 2.1%
price change
1mo
up 8.3%
price change
12-month return
up 36%
market up 11% ·
its own up 17%
F-score
4 / 9
Weak
Altman Z″
3.60
Low risk
P/E
22.1×
price / earnings
PEG
—
P/E / EPS growth
P/B
2.6×
price / book
Earnings yield
up 7.8%
EBIT / enterprise value
Cheaper than
53%
of the market · around average
Revenue growth
up 12%
year on year
EPS growth
down 51%
latest quarter · +24 pts
Sales growth
down 3%
latest quarter · +1 pts
ROE
up 11%
return on equity
Free cash margin
down 1%
-$636.0M FCF
D/E
0.93
long-term debt / equity
Net debt / EBITDA
-0.5×
net cash
Interest cover
—EBIT / interest
Piotroski tests
- operating cash flow is negative
- profitability slipped from last year
- profits not fully backed by cash
- took on more long-term debt
- gross margin narrowed
- profitable on its assets
- short-term liquidity improved
- no new shares issued
- assets working harder
Trade setup
ATR%
4.4%
$9.07 a day · 2×ATR $186.64
RS
65 / 99
vs the universe
Trend
7 / 8
RS under 70
Relative volume
2.5×
vs 50-day average
Up/down volume
1.01
50 sessions
Implied move
—
no scheduled report
Trend template · 7 of 8
- RS rank 70 or higher: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- Material impairment The company disclosed a material impairment - an asset written down below the value the balance sheet had been carrying.
- Profit not backed by cash Reported profit of $472.0M came with -$535.0M of operating cash flow. Profit that cash does not follow is the classic signature of aggressive accounting.
- Gross margin narrowing Gross margin fell from 15.3% to 13.1%. The company is keeping less of each dollar of sales than it did a year ago.
Last reported
Oct 21, 2026
Results reaction
Oct 21, 2026-1% vs market2 sessions after results
Financials
- Gross 13%
- Net 1%
- Free cash -1%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $19.4B | $27.8B | $32.0B | $34.1B | $40.6B | $45.4B |
| Gross margin | 13% | 15% | 15% | 16% | 15% | 13% |
| Operating income | $1.1B | $1.0B | $1.2B | $1.6B | $1.7B | $781.0M |
| Net income | $673.0M | $659.0M | $792.0M | $1.1B | $1.2B | $472.0M |
| Net margin | 3% | 2% | 2% | 3% | 3% | 1% |
| Earnings per share | $11.24 | $11.25 | $13.54 | $18.78 | $20.43 | $8.92 |
| Free cash flow | $1.8B | $2.0B | $682.0M | $1.6B | $544.0M | -$636.0M |
| Free cash margin | 9% | 7% | 2% | 5% | 1% | -1% |
| Cash | $4.2B | $4.4B | $4.0B | $4.8B | $4.7B | $4.2B |
| Long-term debt | $2.1B | $2.2B | $2.2B | $2.2B | $2.9B | $3.8B |
| Shareholders' equity | $2.1B | $2.6B | $3.0B | $4.2B | $4.5B | $4.1B |
| Shares outstanding | 59m | 58m | 58m | 58m | 56m | 51m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Oct 22, 2026 | Quarterly ↗ | Sep 30, 2026 | 22d |
| Jul 23, 2026 | Quarterly ↗ | Jun 30, 2026 | 23d |
| Apr 23, 2026 | Quarterly ↗ | Mar 31, 2026 | 23d |
| Feb 10, 2026 | Annual ↗ | Dec 31, 2025 | 41d |
| Oct 23, 2025 | Quarterly ↗ | Sep 30, 2025 | 23d |
| Jul 24, 2025 | Quarterly ↗ | Jun 30, 2025 | 24d |
| Apr 24, 2025 | Quarterly ↗ | Mar 31, 2025 | 24d |
| Feb 11, 2025 | Annual ↗ | Dec 31, 2024 | 42d |
| Oct 24, 2024 | Quarterly ↗ | Sep 30, 2024 | 24d |
| Jul 25, 2024 | Quarterly ↗ | Jun 30, 2024 | 25d |
| Apr 25, 2024 | Quarterly ↗ | Mar 31, 2024 | 25d |
| Feb 13, 2024 | Annual ↗ | Dec 31, 2023 | 44d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 21, 2026 | Results ↗ |
| Jul 22, 2026 | Results ↗ |
| Jun 10, 2026 | Regulation FD ↗ |
| May 11, 2026 | Director or officer change · Charter or bylaws · Shareholder vote ↗ |
| May 8, 2026 | Regulation FD ↗ |
| Apr 22, 2026 | Results ↗ |
| Feb 26, 2026 | Regulation FD ↗ |
| Feb 6, 2026 | Material agreement · New obligation · Impairment ↗ |
| Feb 5, 2026 | Results ↗ |
| Nov 20, 2025 | Material agreement · New obligation · Other events ↗ |
| Nov 18, 2025 | Regulation FD ↗ |
| Nov 17, 2025 | Regulation FD ↗ |